Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy

Claudia Gonzaga‐Jauregui, Tamar Harel, Tomasz Gambin, +30

Cell Reports

Motor protein mutations cause a new form of hereditary spastic paraplegia

Andrés Caballero-Oteyza, Esra Battaloğlu, Levent Öcek, +12

Neurology

<scp>PLA2G6</scp> mutations associated with a continuous clinical spectrum from neuroaxonal dystrophy to hereditary spastic paraplegia

Burçak Özeş, N. Karagoz, Rebecca Schüle, +14

Clinical Genetics

Neurological DisorderCorticobasal DegenerationGeneticsPathologyPla2g6 Protein +17

Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach

M. Zimoń, Esra Battaloğlu, Yeşim Parman, +24

Neurogenetics

Genetic LandscapeMendelian DisorderGenetic DisorderGeneticsNeuroscience +6

AAV1.NT-3 gene therapy for X-linked Charcot–Marie–Tooth neuropathy type 1

Burçak Özeş, Morgan Myers, Kyle Moss, +8

Gene Therapy

SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K/Akt pathways

Neslihan Zohrap, Özge Saatci, Burçak Özeş, +5

Oncotarget

Ultrasonographic findings in hereditary neuropathy with liability to pressure palsies

Ayşe Oytun Bayrak, İlkay Koray Bayrak, Esra Battaloğlu, +2

Neurological Research

AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in <i>GarsP278KY/+</i> mice

Burçak Özeş, Kyle Moss, Morgan Myers, +4

Brain Communications

Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1

Zarife Sahenk, Burçak Özeş, Darren Murrey, +6

Molecular Therapy — Methods & Clinical Development

AAV1.NT-3 gene therapy prevents age-related sarcopenia

Burçak Özeş, Lingying Tong, Morgan Myers, +3

Aging